142 related articles for article (PubMed ID: 34656655)
21. Effect of reductions in opioid prescribing on opioid use disorder and fatal overdose in the United States: a dynamic Markov model.
Alexander GC; Ballreich J; Mansour O; Dowdy DW
Addiction; 2022 Apr; 117(4):969-976. PubMed ID: 34590369
[TBL] [Abstract][Full Text] [Related]
22. CDC Guideline For Opioid Prescribing Associated With Reduced Dispensing To Certain Patients With Chronic Pain.
Townsend T; Cerdá M; Bohnert A; Lagisetty P; Haffajee RL
Health Aff (Millwood); 2021 Nov; 40(11):1766-1775. PubMed ID: 34747653
[TBL] [Abstract][Full Text] [Related]
23. An Examination of Claims-based Predictors of Overdose from a Large Medicaid Program.
Cochran G; Gordon AJ; Lo-Ciganic WH; Gellad WF; Frazier W; Lobo C; Chang CH; Zheng P; Donohue JM
Med Care; 2017 Mar; 55(3):291-298. PubMed ID: 27984346
[TBL] [Abstract][Full Text] [Related]
24. Naloxone dispensing among the commercially insured population in the United States from 2015 to 2018.
Dunphy C; Zhang K; Guy GP; Jones CM
Prev Med; 2021 Dec; 153():106820. PubMed ID: 34599923
[TBL] [Abstract][Full Text] [Related]
25. Chronic non-cancer pain among adults with substance use disorders: Prevalence, characteristics, and association with opioid overdose and healthcare utilization.
John WS; Wu LT
Drug Alcohol Depend; 2020 Apr; 209():107902. PubMed ID: 32088587
[TBL] [Abstract][Full Text] [Related]
26. Prescription-related risk factors for opioid-related overdoses in the era of fentanyl contamination of illicit drug supply: A retrospective case-control study.
Smolina K; Crabtree A; Chong M; Park M; Mill C; Zhao B; Schütz CG
Subst Abus; 2022; 43(1):92-98. PubMed ID: 32441588
[No Abstract] [Full Text] [Related]
27. Opioid Epidemic or Pain Crisis? Using the Virginia All Payer Claims Database to Describe Opioid Medication Prescribing Patterns and Potential Harms for Patients With Cancer.
LeBaron VT; Camacho F; Balkrishnan R; Yao NA; Gilson AM
J Oncol Pract; 2019 Dec; 15(12):e997-e1009. PubMed ID: 31682546
[TBL] [Abstract][Full Text] [Related]
28. Initial opioid prescription patterns and the risk of ongoing use and adverse outcomes.
Gomes T; Campbell T; Tadrous M; Mamdani MM; Paterson JM; Juurlink DN
Pharmacoepidemiol Drug Saf; 2021 Mar; 30(3):379-389. PubMed ID: 33300138
[TBL] [Abstract][Full Text] [Related]
29. Concurrent prescriptions for opioids and benzodiazepines and risk of opioid overdose: protocol for a retrospective cohort study using linked administrative data.
Liu EY; Tamblyn R; Filion KB; Buckeridge DL
BMJ Open; 2021 Feb; 11(2):e042299. PubMed ID: 33602708
[TBL] [Abstract][Full Text] [Related]
30. A comparison of opioids and benzodiazepines dispensing in Australia.
Islam MM; Wollersheim D
PLoS One; 2019; 14(8):e0221438. PubMed ID: 31425552
[TBL] [Abstract][Full Text] [Related]
31. Vital Signs: Pharmacy-Based Naloxone Dispensing - United States, 2012-2018.
Guy GP; Haegerich TM; Evans ME; Losby JL; Young R; Jones CM
MMWR Morb Mortal Wkly Rep; 2019 Aug; 68(31):679-686. PubMed ID: 31393863
[TBL] [Abstract][Full Text] [Related]
32. Self-reported challenges obtaining ongoing prescription opioids among Australians with chronic non-cancer pain.
Hopkins RE; Campbell G; Degenhardt L; Lintzeris N; Larance B; Nielsen S; Gisev N
Int J Drug Policy; 2022 Jul; 105():103708. PubMed ID: 35544972
[TBL] [Abstract][Full Text] [Related]
33. Patterns and Trends in Receipt of Opioids Among Patients Receiving Treatment for Cancer in a Large Health System.
Sabik LM; Eom KY; Sun Z; Merlin JS; Bulls HW; Moyo P; Pruskowski JA; van Londen GJ; Rosenzweig M; Schenker Y
J Natl Compr Canc Netw; 2022 Mar; 20(5):460-467.e1. PubMed ID: 35231900
[TBL] [Abstract][Full Text] [Related]
34. Inappropriate opioid prescribing practices: A narrative review.
Kim B; Nolan S; Beaulieu T; Shalansky S; Ti L
Am J Health Syst Pharm; 2019 Aug; 76(16):1231-1237. PubMed ID: 31251321
[TBL] [Abstract][Full Text] [Related]
35. Drug Overdose in a Retrospective Cohort with Non-Cancer Pain Treated with Opioids, Antidepressants, and/or Sedative-Hypnotics: Interactions with Mental Health Disorders.
Turner BJ; Liang Y
J Gen Intern Med; 2015 Aug; 30(8):1081-96. PubMed ID: 25650263
[TBL] [Abstract][Full Text] [Related]
36. Mental Health and Benzodiazepine Use Among Patients on Chronic Opioid Therapy.
Smith AY; Kirk JK; Smith PF; Wells BJ
J Am Board Fam Med; 2021; 34(1):99-104. PubMed ID: 33452087
[TBL] [Abstract][Full Text] [Related]
37. Associations between prescribed benzodiazepines, overdose death and buprenorphine discontinuation among people receiving buprenorphine.
Park TW; Larochelle MR; Saitz R; Wang N; Bernson D; Walley AY
Addiction; 2020 May; 115(5):924-932. PubMed ID: 31916306
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of an opioid pain teleconsultation service to address the opioid overdose epidemic in Colorado: A Health First Colorado demonstration project.
Anderson HD; Patterson V; Wright G; Rawlings JE; Moore GD; Utter B; Taylor J; Leonard J; Page RL
J Am Pharm Assoc (2003); 2023; 63(1):301-308. PubMed ID: 36528493
[TBL] [Abstract][Full Text] [Related]
39. Association of Current Opioid Use With Serious Adverse Events Among Older Adult Survivors of Breast Cancer.
Winn AN; Check DK; Farkas A; Fergestrom NM; Neuner JM; Roberts AW
JAMA Netw Open; 2020 Sep; 3(9):e2016858. PubMed ID: 32930779
[TBL] [Abstract][Full Text] [Related]
40. Trends in the Concomitant Prescribing of Opioids and Benzodiazepines, 2002-2014.
Hwang CS; Kang EM; Kornegay CJ; Staffa JA; Jones CM; McAninch JK
Am J Prev Med; 2016 Aug; 51(2):151-160. PubMed ID: 27079639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
